Daniel Guimarães Tiezzi

12PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 14, 2026
Neutrophil-lymphocyte ratio as prognostic factor in metastatic breast cancer.

|Dec 30, 2025
The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy.

Daniel Guimarães Tiezzi, Isabela Panzeri Carlotti Buzatto, Willian Abraham da Silveira

|Oct 09, 2024
Potential biomarkers as a predictive factor of response to primary chemotherapy in breast cancer patients.

F O Buono, R D S Pugliese, W A da Silveira

|Aug 23, 2024
Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer.

Maria Fernanda Imperio Pereira, Isabela Panzeri Carlotti Buzatto, Hélio Humberto Angotti Carrara

|Jul 13, 2024
Machine learning can reliably predict malignancy of breast lesions based on clinical and ultrasonographic features.

I P C Buzatto, S A Recife, L Miguel

|Feb 21, 2024
Converging and evolving immuno-genomic routes toward immune escape in breast cancer.

Juan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado

Pageof 2

Frequent Collaborators

5 joint publications

Jurandyr Moreira de Andrade

4 joint publications

Francisco Jose Candido Dos Reis

3 joint publications

Leticia De Mattos-Arruda

3 joint publications

Hélio Humberto Angotti Carrara